Steven Cohen Inovio Pharmaceuticals, Inc. Transaction History

Point72 Asset Management, L.P.

  • $39.3 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$0.38 - $0.58 $17,207 - $26,264
45,284 Added 130.12%
80,086 $31,000
Q2 2023

Aug 14, 2023
SELL
$0.39 - $0.94 $19,716 - $47,522
-50,556 Reduced 59.23%
34,802 $15,000
Q1 2023

May 15, 2023
BUY
$0.79 - $1.91 $67,432 - $163,033
85,358 New
85,358 $69,000

Others Institutions Holding INO

# of Institutions
14
Shares Held
292K
Call Options Held
0
Put Options Held
0
View Full List

About INOVIO PHARMACEUTICALS, INC.

INO Quotes by TradingView
  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $2.23B
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email